Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...
The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...
ResMed launches AirSense 11, to advance digital health in sleep apnoea for Indians: Our Bureau, Bengaluru Monday, January 6, 2025, 17:30 Hrs [IST] ResMed, the world’s leading he ...
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
Until now, OSA treatment has focused on mechanical support during sleep in the form of positive airway pressure (PAP) therapy. "Today's approval marks the first drug treatment option for certain ...